[2022] Bashyal N., et al., Improving the safety of mesenchymal stem cell-based ex vivo therapy using Herpes Simplex virus thymidine kinase. Mol. Cells. 2022, 5:479-494.
Author
관리자
Date
2024-01-08 20:50
Views
142
Bashyal N., et al., Improving the safety of mesenchymal stem cell-based ex vivo therapy using Herpes Simplex virus thymidine kinase. Mol. Cells. 2022, 5:479-494.
Total 9